妥布霉素
tobramycin;1-epitobramycin;3’-deoxykanamycinb;4-[2,6-diamino-2,3,6-trideoxy-alpha-d-glycopyranosyl]-6-[3-amino-3-deoxy-alpha;6-trideoxy-alpha-d-ribo-hexopyranosyl-(1-4))-2-deoxy-;d-6-trideoxy-alpha-d-ribohexopyranosyl-(1-6))-2-deoxy;d-6-tyrideoxy-alpha-d-ribohexopyranosyl-(1-6))-2-deoxy;deoxykanamycinb;-d-glycopyranosyl]-2-deoxystreptamine;Tobramycin 13C6;Tobramycin Base;Tobramycin Deuterated;gernebcin;nebcin;nebicina;Nebramycin Factor 6;NF 6;nf6;obracin;tobra;Tobracin;tobralex;Tobramax;tobrex;Tyloxapol;O-[3-Amino-3-deoxy-α-D-glucopyranosyl-(1→6)]-O-[2,6-diamino-2,3,6-trideoxy-α-D-ribo-hexopyranosyl-(1→4)]-2-deoxy-D-streptamine;O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1→6)]-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1→4)]-2-deoxy-D-streptamine;Deoxykanamycin B;Tobramycin;Tobramaxin;O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine;Tobramycin (JP17/USP);CHEBI:28864;NEBRAMYCIN;NSC-180514;HMS2092M17;vantobra;KBioSS_001552;KBioGR_001104;Tobramicin;EINECS 251-322-5;Tobrex;Tobramycine;Gotabiotic;TOBRAMYCIN COMPONENT OF TOBRADEX ST;4-(2,6-Diamino-2,3,6-trideoxy-alpha-D-glycopyranosyl)-6-(3-amino-3-deoxy-alpha-D-glycopyranosyl)-2-deoxystreptamine;Tenemycin;BRN 1357507;SR-01000721898-2;Spectrum5_001038;Nebcin;SMR000058793;O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine;Spectrum2_000078;D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1->4)]-2-deoxy-;Tobralex;TOBRAMYCIN (USP MONOGRAPH);Tobramycin Inhalation;BDBM50366778;Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-;torbamycin;VZ8RRZ51VK;TOBRAMYCIN [INN];TOBRAMYCIN (MART.);Tobramycin (USAN:USP:INN:BAN:JAN);(2S,3R,4S,5S,6R)-4-amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol;BRD-K05619559-001-12-7;NSC 180514;CAS-32986-56-4;HMS3713N09;TOBRAMYCIN (EP MONOGRAPH);Spectrum3_000588;DB00684;ZYLET COMPONENT TOBRAMYCIN;TOBRAMYCIN (USP-RS);Tobrased;Tobramicina;O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-6))-2-deoxy-L-streptamine;MLS000069544;NCGC00178852-01;Bethkis;HSDB 3259;TOBRASONE COMPONENT TOBRAMYCIN;Tobradistin;DTXCID903680;Tobramycinum (Latin);Tobi Podhaler;Tobramycin,(S);TOBRAMYCIN [WHO-DD];TOBRADEX ST COMPONENT TOBRAMYCIN;BSPBio_000587;Nebcin (Sulfate);HB4564;O-3-Amino-3-deoxy-?-D-glucopyranosyl-(1-6)-O-[2,6-diamino-2,3,6-trideoxy-?-D-ribohexopyranosyl-(1-4)]-2-deoxy-D-streptamine;SPRC-AB01;Nebicin;Tenebrimycin;SR-05000001726;TOBRAMYCIN [ORANGE BOOK];C18H37N5O9;TobramycinInhala...